Zavicefta, Ceftazidime-Avibactam
Sponsors
Pfizer
Conditions
Acute PyelonephritisBacteremiaHospital Acquired PneumoniaHospital-Acquired PneumoniaIntra-abdominal InfectionUrinary Tract InfectionVentilator-associated Pneumonia
Phase 4
Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)
CompletedNCT04774094
Start: 2021-05-21End: 2023-05-04Updated: 2024-09-19
Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
CompletedNCT04882085
Start: 2021-08-26End: 2023-08-31Updated: 2024-10-21